Kisqali is a new FDA approved breast cancer treatment.
Posted at 2:09 PM, Oct 19, 2018
and last updated 2018-10-19 14:09:46-04
Breast cancer in women diagnosed prior to menopause tends to be more aggressive and metastasize faster than cancer diagnosed after menopause.
Novartis Kisqali is a new FDA improved injection that helps stop cell division in women under 50.
Learn more here.
Copyright 2018 Scripps Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.